Chemoembolization Tace News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Riccardo Lencioni, MD, discusses how TACE, durvalumab, and bevacizumab, could represent a new standard of care in embolization-eligible HCC.

Riccardo lencioniDepartment of surgeryCancers symposiumCritical area pathologyRiccardo lencioniChemoembolization taceUrvalumab imfinziNd bevacizumab avastinHepatocellular carcinomaPhase 3 emerald 1 trial nct03778957